Related Experiment Video
Updated: Jun 10, 2026

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
Published on: December 5, 2019
Turning the RING domain protein MdmX into an active ubiquitin-protein ligase
Saravanakumar Iyappan1, Hans-Peter Wollscheid1, Alejandro Rojas-Fernandez1
1From the Department of Biology and Konstanz Research School Chemical Biology, 78457 Konstanz, Germany.
Abstract:
The related RING domain proteins MdmX and Mdm2 are best known for their role as negative regulators of the tumor suppressor p53. However, although Mdm2 functions as a ubiquitin ligase for p53, MdmX does not have appreciable ubiquitin ligase activity. In this study, we performed a mutational analysis of the RING domain of MdmX, and we identified two distinct regions that, when replaced by the respective regions of Mdm2, turn MdmX into an active ubiquitin ligase for p53. Mdm2 and MdmX form homodimers as well as heterodimers with each other. One of the regions identified localizes to the dimer interface indicating that subtle conformational changes in this region either affect dimer stability and/or the interaction with the ubiquitin-conjugating enzyme UbcH5b. The second region contains the cryptic nucleolar localization signal of Mdm2 but is also assumed to be involved in the interaction with UbcH5b. Here, we show that this region has a significant impact on the ability of respective MdmX mutants to functionally interact with UbcH5b in vitro supporting the notion that this region serves two distinct functional purposes, nucleolar localization and ubiquitin ligase activity. Finally, evidence is provided to suggest that the RING domain of Mdm2 not only binds to UbcH5b but also acts as an allosteric activator of UbcH5b.
Insights
MdmX, a protein regulating tumor suppressor p53, was engineered into an active ubiquitin ligase. Mutational analysis revealed key regions for MdmX
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- Mdm2 and MdmX are RING domain proteins that negatively regulate the tumor suppressor p53.
- Mdm2 acts as a ubiquitin ligase for p53, while MdmX lacks significant ubiquitin ligase activity.
- Understanding MdmX's functional regulation is crucial for cancer therapy development.
Purpose of the Study:
- To investigate the functional domains of MdmX responsible for its lack of ubiquitin ligase activity.
- To engineer MdmX into an active ubiquitin ligase by analyzing Mdm2's RING domain.
- To elucidate the roles of specific MdmX regions in protein interactions and localization.
Main Methods:
- Performed mutational analysis of the MdmX RING domain.
- Replaced specific MdmX regions with corresponding Mdm2 regions.
- Assessed ubiquitin ligase activity in vitro and analyzed protein interactions.
Main Results:
- Identified two distinct regions in MdmX's RING domain that, when substituted with Mdm2 sequences, confer ubiquitin ligase activity.
- One identified region affects dimer stability and interaction with UbcH5b, while the second impacts UbcH5b interaction and nucleolar localization.
- Demonstrated that Mdm2's RING domain binds and allosterically activates UbcH5b.
Conclusions:
- MdmX can be functionally converted into an active ubiquitin ligase through targeted domain swapping with Mdm2.
- Specific regions within the MdmX RING domain are critical for regulating its enzymatic activity and protein interactions.
- The Mdm2 RING domain plays a dual role in binding and activating ubiquitin-conjugating enzymes.
Related Concept Videos
Export of Misfolded Proteins out of the ER
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Unfolded Protein Response

